Movatterモバイル変換

Skip to main page content

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your saved search

Full text links

Elsevier Science full text link

Elsevier Science

Full text links

Actions

.2023 Aug;24(8):848-850.

doi: 10.1016/S1470-2045(23)00341-8. Epub 2023 Jul 13.

Carcinogenicity of aspartame, methyleugenol, and isoeugenol

Elio Riboli¹, Frederick A Beland¹, Dirk W Lachenmeier¹, M Matilde Marques¹, David H Phillips¹, Eva Schernhammer¹, Abdul Afghan¹, Ricardo Assunção¹, Giovanna Caderni¹, J Christopher Corton¹, Gisela de Aragão Umbuzeiro¹, Daphne de Jong¹, Melanie Deschasaux-Tanguy¹, Allison Hodge¹, Junko Ishihara¹, Dan D Levy¹, Daniele Mandrioli¹, Marjorie L McCullough¹, Sarah A McNaughton¹, Takeshi Morita¹, Anne P Nugent¹, Kumiko Ogawa¹, Arun R Pandiri¹, Consolato M Sergi¹, Mathilde Touvier¹, Luoping Zhang¹, Lamia Benbrahim-Tallaa¹, Shirisha Chittiboyina¹, Danila Cuomo¹, Nathan L DeBono¹, Charlotte Debras¹, Aline de Conti¹, Fatiha El Ghissassi¹, Emma Fontvieille¹, Rhea Harewood¹, John Kaldor¹, Heidi Mattock¹, Elisa Pasqual¹, Gabrielle Rigutto¹, Hannah Simba¹, Eero Suonio¹, Susana Viegas¹, Roland Wedekind¹, Mary K Schubauer-Berigan¹, Federica Madia¹

Affiliations

PMID:37454664
DOI: 10.1016/S1470-2045(23)00341-8

Carcinogenicity of aspartame, methyleugenol, and isoeugenol

Elio Riboli et al. Lancet Oncol.2023 Aug.

.2023 Aug;24(8):848-850.

doi: 10.1016/S1470-2045(23)00341-8. Epub 2023 Jul 13.

Authors

Elio Riboli¹, Frederick A Beland¹, Dirk W Lachenmeier¹, M Matilde Marques¹, David H Phillips¹, Eva Schernhammer¹, Abdul Afghan¹, Ricardo Assunção¹, Giovanna Caderni¹, J Christopher Corton¹, Gisela de Aragão Umbuzeiro¹, Daphne de Jong¹, Melanie Deschasaux-Tanguy¹, Allison Hodge¹, Junko Ishihara¹, Dan D Levy¹, Daniele Mandrioli¹, Marjorie L McCullough¹, Sarah A McNaughton¹, Takeshi Morita¹, Anne P Nugent¹, Kumiko Ogawa¹, Arun R Pandiri¹, Consolato M Sergi¹, Mathilde Touvier¹, Luoping Zhang¹, Lamia Benbrahim-Tallaa¹, Shirisha Chittiboyina¹, Danila Cuomo¹, Nathan L DeBono¹, Charlotte Debras¹, Aline de Conti¹, Fatiha El Ghissassi¹, Emma Fontvieille¹, Rhea Harewood¹, John Kaldor¹, Heidi Mattock¹, Elisa Pasqual¹, Gabrielle Rigutto¹, Hannah Simba¹, Eero Suonio¹, Susana Viegas¹, Roland Wedekind¹, Mary K Schubauer-Berigan¹, Federica Madia¹

Affiliation

¹ International Agency for Research on Cancer, Lyon, France.

PMID:37454664
DOI: 10.1016/S1470-2045(23)00341-8

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

[8]ページ先頭

©2009-2025 Movatter.jp